This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

CME Article

Screening for Early Alzheimer’s Disease: Is There Still a Role for the Mini-Mental State Examination?

Aaron D. Benson, BS; Melissa J. Slavin, PhD; Thanh-Thu Tran, BS; Jeffrey R. Petrella, MD; and P. Murali Doraiswamy, MD

Published: April 1, 2005

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

In light of the continuing rise in the population of elderlyindividuals in the United States and the of impaired cognitive function to diminishone’s qualityof life, accurate and effective screening for early recognitionand differentiation between normal age-relatedcognitive decline, mild cognitive impairment (MCI), mildAlzheimer’s disease, and other causes of cognitive declineis desirable. The Mini-Mental State Examination(MMSE)1 is one of the most widely used tools implementedby physicians to evaluate a patient’s cognitive status.24threat

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 7

Quick Links: Dementia , Neurologic and Neurocognitive


Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...